Lyotropic Delivery Systems Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Lyotropic Delivery Systems General Information


Operator of a nano and biotechnology platform intended to develop liquid nano-sized drug delivery vehicles. The company's platform creates solubiliztion of large loads of water-insoluble and poorly-permeable drug molecules as well as bio-macro molecules, enhancing the drug transport across human membrane, enabling patients to increase compliance and quality of life by offering a drug with reduced side-effects and greater convenience.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Hi-Tech Park Building 5/1 Givat Ram Campus
  • POB 39141
  • Jerusalem 9139002
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lyotropic Delivery Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue
To view Lyotropic Delivery Systems’s complete valuation and funding history, request access »

Lyotropic Delivery Systems Executive Team (2)

Name Title Board Seat Contact Info
Nissim Garti Co-Founder & Chief Executive Officer
Sharon Garti-Levi Co-Founder & Chief Technology Officer
To view Lyotropic Delivery Systems’s complete executive team members history, request access »

Lyotropic Delivery Systems Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
8200 EISP Accelerator/Incubator 000 0000 000000 0
To view Lyotropic Delivery Systems’s complete investors history, request access »